Anti-ZIKV E domain III [SMZAb1]
Ab01256-10.0
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Overview
- SupplierAbsolute Antibody
- Product NameAnti-ZIKV E domain III [SMZAb1]
- Delivery Days Customer7
- Antibody SpecificitySMZAb1 binds to domain III of the ZIKV E protein.
- Application Supplier NoteELISA was used to confirm SMZAb1 binds to the ZIKV E domain, and neutralisation assays identified the IC50 of SMZAb1 as 5.4 ng/ml. Four macaques were injected with a cocktail of anti-Zika antibodies (SMZAb1, SMZAb2, SMZAb5) and then infected with ZIKV virus. The antibody cocktail appeared to confer sterilising immunity on the treated macaques and completely prevented viral replication, which was not seen with the control group (Magnani et al, 2017).
- ApplicationsELISA, Neutralisation/Blocking
- Applications SupplierELISA; therapeutic; neutralisation assays
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSMZAb1
- HostHuman
- IsotypeIgG1
- Protein IDQ91KX7
- Protein NameEnvelope protein
- Scientific DescriptionThis reformatted human antibody was made using the variable domain sequences of the original Human IgG format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityVirus
- Reactivity SupplierZika virus
- Reactivity Supplier NoteAntibody genes were cloned from blood-derived plasmablasts of a ZIKV-infected human subject from Colombia in the acute phase. Amplified heavy and light chains were tested for neutralisation, and SMZAb1 was selected from this.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203